ArticleEBioMedicine2019

Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.

Na Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.